CVKD

Latest SEC Filings & News for CVKD

2 most recent filings and news items mentioning CVKD. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/CVKD/news?limit=20"

Pull CVKD filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

M&AJul 21, 2026Positive

Cadrenal Therapeutics launches partnership process for cardiac critical care assets

Cadrenal announced a strategic partnering process for its cardiology assets following positive Phase 2 data presentation and reorganization of its portfolio into a dedicated franchise.

View filing at SEC.gov →

RegulatoryJun 18, 2026Positive

Cadrenal to seek FDA rare pediatric disease designation for tecarfarin in Kawasaki disease

Cadrenal Therapeutics announced plans to submit a Rare Pediatric Disease Designation request to the FDA for tecarfarin to treat pediatric Kawasaki disease patients with coronary artery aneurysms. Approval could qualify the company for a Priority Review Voucher valued around $200

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.